News

LivaNova PLC today announced it received U.S. FDA 510(k) clearance and CE Mark for its Essenz™ In-Line Blood ... quarter and full-year 2024 results and issued full-year 2025 guidance ...
Last week, the FDA released a trio of guidelines clarifying the way it plans to evaluate devices that go through the 510(k) pathway. The agency is asking manufacturers to avoid predicate devices ...
SAN FRANCISCO, Sept. 16, 2024 /PRNewswire/ -- Piccolo Medical, Inc. (Piccolo) today announced that it has received clearance from the U.S. Food and Drug Administration (FDA) to market its innovative ...
DURHAM, N.C., Dec. 5, 2022 /PRNewswire/ -- Deep Blue Medical Advances announced today it has received an additional 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its T-Line ...
As part of MDUFA V, the FDA committed to cutting the total time to decision for 510(k) submissions from 128 calendar days in 2023 to 112 calendar days in 2027. The goal is to issue a decision on ...